$RYAN

RYAN SPECIALTY HOLDINGS, INC.

No enriched coverage for $RYAN in the last 7 days.

—
$1.6M
MULSHINE BRENDAN MARTIN
0%
See all $RYAN insider activity →
Low

Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?

Ryan Specialty Holdings' shares rose 9% in 3 months, outperforming the industry and S&P 500. The rally was driven by index inclusion, better-than-expected Q2 results, improved margin outlook, and capital returns. The company reported 74 cents adjusted EPS, up 12.1% YoY, and raised its 2026 EBITDAC margin guidance. It also expanded underwriting capabilities and repurchased shares worth $260 million. Analysts expect 11.2% EPS growth in 2026.

Ryan Specialty (RYAN): Vulcan Value Partners reports 7.9M-share, 6.11% stake

Ryan Specialty Holdings (RYAN) says Vulcan Value Partners, a Delaware investment adviser, filed an amended Schedule 13G showing 7,912,669 shares, or 6.11% of the class, as of June 30, 2026. Vulcan reports sole voting power over 5,011,724 shares and sole dispositive power over 7,912,669 shares for advisory clients.

RYAN sentiment & insider activity

Recent RYAN coverage spans earnings, financial news and insider activity.

In the last 30 days, RYAN insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($1.6M). The most active reporter was MULSHINE BRENDAN MARTIN, Co-President and CRO, with 1 filing.

What's driving RYAN

  • No new information; reiterates previously released earnings and guidance.

    zacks.com · Sep 23, 2026

  • Insider sale may signal reduced confidence or liquidity need, potentially pressuring the stock short-term.

    SEC EDGAR · Sep 9, 2026

  • This is a disclosed ownership update that can affect perceived shareholder base and potential influence, but it is not a control or deal event.

    stocktitan.net · Aug 7, 2026

  • The filing is a corporate compensation mechanics update intended to keep the second tranche net-neutral to share count.

    SEC EDGAR 8-K · Aug 7, 2026

  • Ryan Specialty Underwriting Managers (RSUM) launched Tera Underwriters, a managing general underwriter, and a specialty insurance programme for computing hardware infrastructure in US industrial-scale data centres. The programme can provide over $1 billion per policy via a $625 million lead binder plus excess capital, backed by A+-rated capital, available through RT Specialty. Expansion internationally is planned for Q4 2026.

    reinsurancene.ws · Aug 6, 2026

AlphAI scores every news story that mentions RYAN with an AI model for sentiment and relevance, and aggregates insider trades from RYAN SPECIALTY HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RYAN

Score
$RYANLow

Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?

Ryan Specialty Holdings' shares rose 9% in 3 months, outperforming the industry and S&P 500. The rally was driven by index inclusion, better-than-expected Q2 results, improved margin outlook, and capital returns. The company reported 74 cents adjusted EPS, up 12.1% YoY, and raised its 2026 EBITDAC margin guidance. It also expanded underwriting capabilities and repurchased shares worth $260 million. Analysts expect 11.2% EPS growth in 2026.

RYAN SPECIALTY HOLDINGS, INC. (RYAN): Entry into a Material Definitive Agreement

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement . On August 4, 2026, Ryan Specialty Holdings, Inc. (the “Company”) and the Ryan Stock Option Trust (the “Trust”), a trust of which Patrick G. Ryan, the Company’s Executive Chairman, and Shirley W. Ryan, serve as trustees, enter

Ryan Specialty's Tera launches insurance programme for industrial

Ryan Specialty Underwriting Managers (RSUM) launched Tera Underwriters, a managing general underwriter, and a specialty insurance programme for computing hardware infrastructure in US industrial-scale data centres. The programme can provide over $1 billion per policy via a $625 million lead binder plus excess capital, backed by A+-rated capital, available through RT Specialty. Expansion internationally is planned for Q4 2026.

Ryan Specialty (RYAN) Stock Faces Margin Pressure Behind A 57.7x P/E

Simply Wall St reports Ryan Specialty Holdings (NYSE:RYAN) stock was about flat at $44.16 after a 90-day run. It cites Q2 organic revenue of about $917m and adjusted EPS of $0.74, alongside a 57.7x P/E. The article highlights margin pressure, with adjusted EBITDAC margin at 35.7% and guidance for a 50 to 100 bps full-year decline.

Vulcan Value Partners is Bullish on Ryan Specialty Holdings (RYAN)

Vulcan Value Partners’ Q2 2026 investor letter highlighted Ryan Specialty Holdings (NYSE:RYAN). The firm cited 11.8% Q1 organic revenue growth but said Ryan cut its 2026 organic revenue outlook to mid-single-digit from high-single-digit. Vulcan noted robust E&S submission growth despite 25% to 35% property rate declines, plus a $300MM share repurchase authorization increase. RYAN closed at $44.09 on July 30, 2026.

$RYANMedAI 8/10

These Analysts Boost Their Forecasts On Ryan Specialty After Better-Than-Expected Q2 Earnings - Ryan Spec

Ryan Specialty Holdings (NYSE:RYAN) reported Q2 earnings of 74 cents per share, above the 60 cents consensus, and sales of $916.647 million versus $872.957 million expected. Shares rose 11.7% to $49.25 pre-market. After the results, Barclays raised its price target to $48 and Keefe, Bruyette & Woods to $54, both maintaining positive ratings.

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.

$RYANMed

RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 per diluted share - - Adjusted EBITDAC* grew 6.0% year-over-year to

Related tickers